Gynecological Cancer Frontiers: A Recap of SGO's Recent News -written by Poonam Chanchlani (BCA, Data Science)

Ovarian cancer poses a unique challenge due to its elusive nature, often remaining undetected until it reaches an advanced stage. Despite being the fifth leading cause of cancer-related deaths in women, early diagnosis remains rare, and outcomes remain poor. However, there's a new perspective emerging in the fight against ovarian cancer.

 

The Fallopian Tube Connection:

Recent research suggests that the fallopian tubes, not the ovaries, might be the origin of ovarian cancer. The Ovarian Cancer Research Alliance (OCRA) has issued a compelling recommendation: individuals undergoing pelvic surgeries for noncancerous reasons should consider having their fallopian tubes removed, a procedure known as opportunistic salpingectomy, as a preventive measure against ovarian cancer. Gynecologic oncologists at NYU Langone’s Perlmutter Cancer Center have embraced this recommendation, targeting women at average risk who have already undergone or plan to undergo pelvic procedures, such as hysterectomies, cyst removals, endometriosis treatments, or tubal ligations.

 

Expert on Preventive Measures :

Dr. Eva Chalas, a leading gynecologic oncologist and physician director of Perlmutter Cancer Center at NYU Langone Hospital—Long Island, emphasizes the significance of these recommendations. They renew earlier suggestions from the Society of Gynecologic Oncology (SGO) and the American College of Obstetrics and Gynecology, issued in 2013 and 2015, respectively. These recommendations are rooted in data showing that precursor ovarian cancer lesions were found in fallopian tubes in about 75 percent of patients who had their fallopian tubes and ovaries removed, even among those with cancer.

Opting for fallopian tube removal has an additional advantage: preserving ovarian function. The ovaries secrete crucial hormones, including estrogen and progesterone. Their removal, known as oophorectomy, can induce early-onset menopause, carrying its own set of risks, including cardiovascular disease and osteoporosis. Dr. Deanna Gerber, another gynecologic oncologist at Perlmutter Cancer Center, highlights the importance of preserving ovaries for overall health and well-being.

 

While current recommendations target obstetricians–and gynecologists, Dr. Gerber advocates for a broader approach. She suggests that surgeons conducting various pelvic procedures, including colorectal, bladder, and gallbladder surgeries, should consider fallopian tube removal as an option.

 

Dr. Chalas adds that surgeons performing abdominal procedures could collaborate with gynecologists or, if capable, conduct salpingectomies themselves. Moreover, colorectal cancer surgeons should consult with gynecologists, especially when patients may carry the genetic mutation for Lynch syndrome, which elevates the risk of ovarian, fallopian tube, and uterine cancers.

Raising Awareness for a Healthier Future :

In essence, these recommendations aim to raise awareness about the potential benefits of removing fallopian tubes during various pelvic surgeries. By considering these preventive measures, we can potentially reduce the risk of ovarian cancer and improve overall women's health.